Anna Dimantov-Algamas

Anna Dimantov-Algamas has a diverse work experience in the pharmaceutical industry. Anna is currently working as the RA/QA Director at Mileutis Ltd. since December 2020. Prior to this, they worked at MediWound from an unspecified start date in 2018 until December 2020, where they held the role of RA Manager. In this role, they were responsible for developing and executing the company's regulatory strategy for developmental products. Anna also communicated with health authorities and managed routine regulatory maintenance.

Before joining MediWound, Anna worked at SciVac Limited for a significant period from an unspecified start date in 2010 until 2018. During their time at SciVac Limited, they held the positions of Quality Director/CMC. In this role, they managed various quality departments and executed the company's quality strategy. Anna was responsible for evaluating and approving sterile products for marketing, managing deviations and change controls, and conducting inspections and audits. Additionally, they handled CMC queries from regulatory authorities.

Prior to SciVac Limited, Anna worked at PPS as a QA Manager from an unspecified start date in 2005 until 2008. Anna also gained experience at InterPharm Laboratories Ltd. as a QC from an unspecified start date in 1995 until 2000.

Overall, Anna Dimantov-Algamas has a strong background in regulatory affairs, quality assurance, and quality control in the pharmaceutical industry.

Anna Dimantov-Algamas pursued their education in the field of science and biotechnology. Anna began their academic journey in 1991 at the Technion - Israel Institute of Technology, where they earned an Engineer's Degree in Biotechnology and Food Engineering in 1995. Continuing their studies, they then obtained a Master of Science (MSc) degree in Biotechnology from the same institution between 2000 and 2002. Anna furthered their education by pursuing a PhD in Biochemistry at The Hebrew University of Jerusalem from 2006 to 2011. As of now, there is no specific information available regarding any additional certifications they may have obtained.